2A2 anti-ceramide mAb

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name2A2 anti-ceramide mAb
Drug Alias Name2A2
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionApoptosis inhibitors
TargetsUpdating
Therapy Area/IndicationsRadiation sicknessGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPxRadia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPxRadia Inc
Active IndicationsN/A
Inactive IndicationsRadiation sicknessGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A